Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Integris BioServices is a private life sciences services company best known through its operating brand KCAS Bio, a full-service bioanalytical and biomarker contract research organization. The company supports biopharma, biotech, and animal health clients from early discovery through preclinical and clinical development to product registration, with capabilities spanning PK/TK bioanalysis, biomarkers, immunogenicity, flow cytometry, molecular assays, biodistribution, dose formulation analysis, and central lab support. KCAS Bio emphasizes both large- and small-molecule development and has positioned itself as a specialist partner for complex and emerging therapeutic modalities, including cell and gene therapies. The business operates laboratories in Olathe, Kansas and the greater Philadelphia area, plus a site in Lyon, France and a strategic alliance in Melbourne, Australia. It is backed by Vitruvian Partners and serves global drug developers rather than advancing an internal therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Integris BioServices.